主 頁 > 新 聞 及 資 訊

新 聞 及 資 訊   Overseas Drug Alert (29 May 2009) – English only   US FOOD AND DRUG ADMINISTRATION Centocor Ortho Biotech reminded healthcare professionals of the risk of serious fungal infections associated with Simponi (golimumab), a Tumor Necrosis Factor-α (TNF-α) blocker. This has resulted in delays in appropriate antifungal treatment, sometimes even resulting in death. It is important that all adverse events potentially associated with Simponi be reported so that the prescribing information can be updated appropriately as post-approval experience is gathered. http://www.fda.gov/medwatch/safety/2009/safety09.htm#Simponi Situation in Hong Kong: Golimumab is not registered in HK. Ends/Friday, May 29, 2009 Issued at HKT 12:30